etvax
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 8, 2021 (NCT05178134)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Escherichia coliImmunity, active
Escherichia coli immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05178134 | Phase 2 | Nov 8, 2021 | Aurevia, Scandinavian Biopharma AB, University of Gothenburg |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aurevia | For profit | 1 | 0 | 1 | 2021 |
| Scandinavian Biopharma AB | For profit | 1 | 1 | 1 | 2021 |
| University of Gothenburg | Academic/Hospital | 1 | 0 | 1 | 2021 |
3 organizations
Page 1 / 1